BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 14, 2003
View Archived Issues
FDA Accepts ImClone's Erbitux Filing, Grants It Priority Review
Read More
Elixir Pharmaceuticals Gets $19M In Second B' Round
Read More
Georgia, Among Others, Seeking To Grow Through Life Sciences
Read More
Xcyte Seeking $75M In Second Attempt At Initial Public Offering
Read More
Other News To Note
Read More
Corgentech, BMS Enter Graft Deal Valued At Up To $250M
With two Phase III trials under way testing its treatment to prevent vein-graft failure after surgery, Corgentech Inc. is joining with Bristol-Myers Squibb Co. in a deal that's expected to get revenue flowing better. (BioWorld Today)
Read More